The biotech company Amniotics has developed technologies for extracting and refining amniotic fluid stem cells for cutting-edge therapy methods. In 2020, the company will enter the clinical phase, which may lead to a breakthrough in future cell therapies.
Unique stem cells from amniotic fluid (article in Swedish)
In the News
3 July, 2020